[Treatment of toxic hepatitis in COVID-19 patients].

I V Maev, R I Shaburov, A I Pavlov, A I Molodova, A G Karakozov, S P Kazakov, E G Lebedeva, A F Ivolgin,M N Eremin, O B Levchenko

Terapevticheskii arkhiv（2023）

引用 0|浏览4

暂无评分

摘要

The use of drugs with hepatoprotective effect in the form of monotherapy in groups 1 (UDCA) and 2 (ademethionine) showed a low therapeutic effect with positive dynamics of clinical and laboratory indicators of toxic hepatitis activity. The use of combined treatment in group 3 (UDCA and ademethionine) demonstrated the maximum therapeutic effect, pronounced positive dynamics in the form of normalization of clinical and laboratory indicators of toxic hepatitis activity.

查看译文

关键词

toxic hepatitis,treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要